FinalSpark
PrivateTotal Funding Raised
$1.26M
Company Overview
FinalSpark is a biotechnology company that develops bioprocessors utilizing human neurons for energy-efficient computing and research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Computing Hardware, Biotech Equipment
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FinalSpark Comparables
Compare FinalSpark with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cortical Labs | 85% | |
| Archean Sciences, Inc. | 77% | |
| The Biological Computing Co. | 69% | |
FinalSpark Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 182% MoM.
- Nov 6, 2025
Monthly visitors grew 133% MoM, reaching 26.1K.
FinalSpark Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FinalSpark's valuation, stock price, and market status.